Balanced news tone
News Sentiment
TWST sentiment intelligence
Twist Bioscience Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-8.7% over one week, +19.0% over four weeks, trend active, and materially above fair value.
Twist Bioscience Is Maintained at Buy by Canaccord Genuity
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Twist Bioscience Insider Sold Shares Worth $1,793,600, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 20:50
- Source
- MT Newswires
Twist Bioscience (TWST) officer sells 14,205 shares in planned trade
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Stock Titan
Multiple insider sales and a 346-share vesting at TWST (NASDAQ: TWST)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
Emily Leproust sells TWST shares (NASDAQ: TWST) in multiple trades
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
Investor’s Favored Twist Bioscience’s (TWST) Association with Technology Companies
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 07:00
- Source
- Market source
Twist Bioscience (TWST) Stock Looks 42.9% Overvalued After Bullish Analyst Calls
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 18 Jun 2026 07:00
- Source
- simplywall.st
Twist Bioscience: Huge Downside, With Little Hope Of Profits (NASDAQ:TWST)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- Seeking Alpha
Twist Bioscience (TWST) HR chief sells shares after exercising options
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- Stock Titan
Twist Bioscience (TWST) Stock Could Be 25.5% Overvalued After Its Recent Rally
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Twist Bioscience (TWST) Surges 9.3%: Is This an Indication of Further Gains?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Market source
How The Investment Story For Twist Bioscience (TWST) Is Evolving With Recent Developments
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Market source
Twist Bioscience (TWST) CEO Leproust sells 49,299 shares via 10b5-1 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Stock Titan
Affiliate files Form 144 to sell 500 shares of TWST (NASDAQ: TWST)
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 26 May 2026 07:00
- Source
- Stock Titan
Adam Laponis files sale notice for TWST (NASDAQ: TWST) including recent trades
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Stock Titan
Twist Bioscience (NASDAQ: TWST) insider files to sell 688 shares
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Stock Titan
Earnings call transcript: Twist Bioscience Q2 2026 EPS miss, stock rises
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- Investing.com
ARK Investment Management reports 10.35% stake in Twist Bioscience (NASDAQ: TWST)
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 30 Apr 2026 07:00
- Source
- Stock Titan
500-share sale listed; TWST (NASDAQ: TWST) Form 144 notice
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Stock Titan
Emily Leproust sells multiple TWST shares (NASDAQ: TWST)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Apr 2026 07:00
- Source
- Stock Titan
Insider share sales disclosed — Company (NASDAQ: TWST) lists recent dispositions
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Apr 2026 07:00
- Source
- Stock Titan
Twist Bioscience Expands Antibody Discovery With Invenra Bispecific Platform Deal
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 25 Feb 2026 08:00
- Source
- simplywall.st
Twist Bioscience Corporation (NASDAQ:TWST) Held Back By Insufficient Growth Even After Shares Climb 30%
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jan 2026 08:00
- Source
- simplywall.st
ETFs Investing in Twist Bioscience Corp. Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Sep 2025 15:08
- Source
- TradingView